Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))

Alberto Gil-Jimenez; Jeroen van Dorp; Alberto Contreras-Sanz; Kristan van der Vos; Daniel J. Vis; Linde Braaf; Annegien Broeks; Ron Kerkhoven; Kim E. M. van Kessel; María José Ribal; Antonio Alcaraz; Lodewyk F. A. Wessels; Roland Seiler; Jonathan L. Wright; Lourdes Mengual; Joost Boormans; Bas W. G. van Rhijn; Peter C. Black; Michiel S. van der Heijden

doi:https://doi.org/10.1016/j.eururo.2023.03.002

Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))

Alberto Gil-Jimenez, Jeroen van Dorp, Alberto Contreras-Sanz, Kristan van der Vos, Daniel J. Vis, Linde Braaf, Annegien Broeks, Ron Kerkhoven, Kim E. M. van Kessel, María José Ribal, Antonio Alcaraz, Lodewyk F. A. Wessels, Roland Seiler, Jonathan L. Wright, Lourdes Mengual, Joost Boormans, Bas W. G. van Rhijn, Peter C. Black, Michiel S. van der Heijden

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

The authors regret that the following statement regarding author contributions was missed: Kristan van der Vos is currently a Scientific Editor for Cell Reports Medicine, which is published by Elsevier. Dr van der Vos was not involved in the peer-review process or editorial discussions about this manuscript. The authors would like to apologise for any inconvenience caused.

Original language	English
Pages (from-to)	e165
Journal	European Urology
Volume	83
Issue number	6
Early online date	2023
DOIs	https://doi.org/10.1016/j.eururo.2023.03.002
Publication status	Published - Jun 2023

Access to Document

https://doi.org/10.1016/j.eururo.2023.03.002

Cite this

Gil-Jimenez, A., van Dorp, J., Contreras-Sanz, A., van der Vos, K., Vis, D. J., Braaf, L., Broeks, A., Kerkhoven, R., van Kessel, K. E. M., Ribal, M. J., Alcaraz, A., Wessels, L. F. A., Seiler, R., Wright, J. L., Mengual, L., Boormans, J., van Rhijn, B. W. G., Black, P. C., & van der Heijden, M. S. (2023). Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023)). European Urology, 83(6), e165. https://doi.org/10.1016/j.eururo.2023.03.002

Gil-Jimenez, Alberto ; van Dorp, Jeroen ; Contreras-Sanz, Alberto et al. / Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83 : 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023)). In: European Urology. 2023 ; Vol. 83, No. 6. pp. e165.

@article{ffa4fb1273d04b3db67be4854e0ed208,

title = "Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))",

abstract = "The authors regret that the following statement regarding author contributions was missed: Kristan van der Vos is currently a Scientific Editor for Cell Reports Medicine, which is published by Elsevier. Dr van der Vos was not involved in the peer-review process or editorial discussions about this manuscript. The authors would like to apologise for any inconvenience caused.",

author = "Alberto Gil-Jimenez and {van Dorp}, Jeroen and Alberto Contreras-Sanz and {van der Vos}, Kristan and Vis, {Daniel J.} and Linde Braaf and Annegien Broeks and Ron Kerkhoven and {van Kessel}, {Kim E. M.} and Ribal, {Mar{\'i}a Jos{\'e}} and Antonio Alcaraz and Wessels, {Lodewyk F. A.} and Roland Seiler and Wright, {Jonathan L.} and Lourdes Mengual and Joost Boormans and {van Rhijn}, {Bas W. G.} and Black, {Peter C.} and {van der Heijden}, {Michiel S.}",

note = "Publisher Copyright: {\textcopyright} 2023 European Association of Urology",

year = "2023",

month = jun,

doi = "https://doi.org/10.1016/j.eururo.2023.03.002",

language = "English",

volume = "83",

pages = "e165",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "6",

}

Gil-Jimenez, A, van Dorp, J, Contreras-Sanz, A, van der Vos, K, Vis, DJ, Braaf, L, Broeks, A, Kerkhoven, R, van Kessel, KEM, Ribal, MJ, Alcaraz, A, Wessels, LFA, Seiler, R, Wright, JL, Mengual, L, Boormans, J, van Rhijn, BWG, Black, PC & van der Heijden, MS 2023, 'Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))', European Urology, vol. 83, no. 6, pp. e165. https://doi.org/10.1016/j.eururo.2023.03.002

Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023)). / Gil-Jimenez, Alberto; van Dorp, Jeroen; Contreras-Sanz, Alberto et al.
In: European Urology, Vol. 83, No. 6, 06.2023, p. e165.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83

T2 - 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))

AU - Gil-Jimenez, Alberto

AU - van Dorp, Jeroen

AU - Contreras-Sanz, Alberto

AU - van der Vos, Kristan

AU - Vis, Daniel J.

AU - Braaf, Linde

AU - Broeks, Annegien

AU - Kerkhoven, Ron

AU - van Kessel, Kim E. M.

AU - Ribal, María José

AU - Alcaraz, Antonio

AU - Wessels, Lodewyk F. A.

AU - Seiler, Roland

AU - Wright, Jonathan L.

AU - Mengual, Lourdes

AU - Boormans, Joost

AU - van Rhijn, Bas W. G.

AU - Black, Peter C.

AU - van der Heijden, Michiel S.

PY - 2023/6

Y1 - 2023/6

N2 - The authors regret that the following statement regarding author contributions was missed: Kristan van der Vos is currently a Scientific Editor for Cell Reports Medicine, which is published by Elsevier. Dr van der Vos was not involved in the peer-review process or editorial discussions about this manuscript. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the following statement regarding author contributions was missed: Kristan van der Vos is currently a Scientific Editor for Cell Reports Medicine, which is published by Elsevier. Dr van der Vos was not involved in the peer-review process or editorial discussions about this manuscript. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85149814572&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.eururo.2023.03.002

DO - https://doi.org/10.1016/j.eururo.2023.03.002

M3 - Comment/Letter to the editor

C2 - 36907692

SN - 0302-2838

VL - 83

SP - e165

JO - European Urology

JF - European Urology

IS - 6

ER -

Gil-Jimenez A, van Dorp J, Contreras-Sanz A, van der Vos K, Vis DJ, Braaf L et al. Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023)). European Urology. 2023 Jun;83(6):e165. Epub 2023. doi: https://doi.org/10.1016/j.eururo.2023.03.002

Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83: 313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))

Abstract

Access to Document

Other files and links

Cite this